Trump's 200% tariff bomb on generic drugs: Here's how India could be hit
Washington DC/IBNS: US President Donald Trump has announced a phased imposition of tariffs on imported generic medicines, culminating in a 200 percent duty, in a move that is likely to impact several countries, including India.